# The Evolution of Hemophilia Treatment with Dr. Ken Friedman

Page: https://stenobird.com/podcast/beyond-the-bleeds-7074228/the-evolution-of-hemophilia-treatment-with-dr-ken-friedman
Text version: https://stenobird.com/podcast/beyond-the-bleeds-7074228/the-evolution-of-hemophilia-treatment-with-dr-ken-friedman.md
Podcast: [Beyond the Bleeds](https://stenobird.com/podcast/beyond-the-bleeds-7074228)
Published: 2026-06-22T05:00:00+00:00
Episode link: https://hemophiliaoutreach.org/evolution-of-hemophilia-treatment/
Audio file: https://media.blubrry.com/3770961/content.blubrry.com/3770961/History_of_Hemophelia_Audio.mp3
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/beyond-the-bleeds-7074228/episodes/the-evolution-of-hemophilia-treatment-with-dr-ken-friedman
Duration seconds: 2394

## Resource

Today on Beyond the Bleeds , Heather and John are joined by Dr. Ken Friedman from Versiti Blood Center and HOC for a conversation about the evolution of hemophilia treatment. Drawing on decades of experience in hematology and bleeding disorders care, Dr. Friedman shares how treatment has changed over time and what those advances have meant for patients and families. The discussion begins with the earliest approaches to hemophilia care, when treatment options were extremely limited. Patients often relied on rest, immobilization, blood transfusions, and supportive care while hoping bleeds would resolve on their own. Dr. Friedman explains how the development of cryoprecipitate, plasma-derived factor concentrates, and home infusions dramatically changed what was possible for people living with bleeding disorders. The conversation also examines the challenges the bleeding disorders community faced during the HIV and hepatitis crisis of the 1980s. Dr. Friedman discusses the transition to recombinant factor products, the rise of prophylactic treatment, and how these advances helped reduce bleeding complications. As treatments improved, patients were able to live more active lives and spend less time managing bleeds. Finally, the group looks toward the future of hemophilia care. From gene therapy to non-factor and rebalancing therapies, Dr. Friedman explains how emerging treatments continue to reshape care for people living with bleeding disorders. The episode highlights how far treatment has come and the progress that continues to improve the lives of patients and families. “The initial care of hemophilia was mostly watch and wait and hope that you get better.” — Dr. Ken Friedman This episode of Beyond the Bleeds explores: Early approaches to treating hemophilia and bleeding…

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/beyond-the-bleeds-7074228/episodes/the-evolution-of-hemophilia-treatment-with-dr-ken-friedman/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/beyond-the-bleeds-7074228/the-evolution-of-hemophilia-treatment-with-dr-ken-friedman.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.